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with ICH and to determine whether differences in care and in-hospital outcomes were present across racial/ethnic groups.
Methods
GWTG-Stroke Registry
GWTG-Stroke Registry is an ongoing, voluntary, national stroke registry and performance improvement program sponsored by the American Heart Association/American Stroke Association. Details of the design and conduct of the GWTG-Stroke Registry have been previously described. 12 Standardized data collection includes patient demographics, medical history, diagnostic testing, brain imaging, inhospital treatment, and outcomes. The validity and reliability of data collection in the Registry have been reported in previous research. 13 Quintiles serves as the data collection and coordination center for GWTG-Stroke. The Duke Clinical Research Institute serves as the data analysis center and has an agreement to analyze the aggregate deidentified data for research purposes.
Study Population
Our analyses included 197 160 patients with ICH in GWTG-Stroke hospitals between April 2003 and January 2012. We excluded 62 252 transfer-in and 4724 transfer-out patients because performance measures and in-hospital outcomes could not be tracked after interhospital transfer. Consistent with the 1997 Office of Management and Budget categories of 5 racial groups, 14 the GWTG-Stroke records race as white, black, Asian, American Indian or Alaska Native, and Native Hawaiian or other Pacific Islander. Hispanic status is recorded separately. For this study, we restricted the analysis to 4 mutually exclusive racial/ethnicity groups: non-Hispanic black (referred to as black), non-Hispanic white (referred to as white), Hispanic regardless of race (referred to as Hispanic), and Asian. Patients who had missing information on race or ethnicity were excluded (n=344). Patients who were classified as American Indian or Alaska Native and Native Hawaiian or other Pacific Islander were excluded because of heterogeneous population and relatively small size within each group (total n=4872). Finally, we excluded 387 sites with fewer than 10 ICH cases to obtain a reliable estimate of performance and outcome measures. After these exclusions, our study population consisted of 123 623 patients with ICH from 1198 hospitals.
Performance and Outcome Measures
The following predefined GWTG-Stroke performance measures were used to compare ICH care processes. 8, 15 Deep vein thrombosis prophylaxis (DVT prophylaxis) administrated by the end of hospital day 2; counseling or medication to help quit smoking for current or recent smokers (smoking cessation); assessment for rehabilitation services (rehabilitation assessment); dysphagia screening before any oral intake, including water or medications (dysphagia screening); stroke education provided to patient and caregiver (stroke education); and door to computed tomographic (CT) time ≤25 minutes. The primary outcome measure was in-hospital all-cause mortality. Secondary outcomes included length of stay, discharge destination (home, skill nursing facility, inpatient rehabilitation, and hospice), comfort measures only (November 2009 and later data), and ambulatory status at discharge.
Statistical Analysis
Baseline characteristics were compared among white, black, Hispanic, and Asian ICH patients by Pearson χ 2 test for categorical variables and Wilcoxon rank-sum test for continuous variables. Multivariable logistic regression analyses were performed to investigate the relationship between race/ethnicity and each of the performance and outcome measures. These analyses adjusted for demographics and clinical variables, including age, sex, history of atrial fibrillation/flutter, previous stroke/ transient ischemic attack, coronary artery disease/previous myocardial infarction, carotid stenosis, diabetes mellitus, peripheral vascular disease, hypertension, dyslipidemia, current smoking, and body mass index. Adjustments for hospital-level characteristics included geographic region, bed size, teaching status, annual stroke volume, and primary stroke center status. Because different racial/ethnic groups might live in different neighborhoods and systematically used different hospitals, we included a hospital-level term of percentage of minority patients to distinguish hospital-level determinants from patient-level determinants better. We also included adjustment for calendar time to account for improvement in care over time. Because age and National Institutes of Health Stroke Scale (NIHSS) are 2 of the major determinants of clinical outcomes, 16 we further stratified the analyses by age group (18-49, 50-59, 60-74, and ≥75 years) and performed subgroup analysis among patients with initial NIHSS documented (n=47 408) using the same approach described above with NIHSS for further risk adjustment. Our analyses accounted for within-hospital clustering using a generalized estimating equations approach.
All statistical analyses were performed using SAS version 9.3 (SAS Institute Inc). The Institutional Review Board of the Duke University Health System approved the study.
Results
Among 123 623 patients with ICH, the racial/ethnic distribution were 67.3% (83 216) white, 17.9% (22 147) black, 8.5% (10 519) Hispanic, and 6.3% (7741) Asian. Table 1 compares baseline characteristics by 4 racial/ethnic groups. Because of the large sample size, some P values may be statistically significant but of little clinical relevance. When compared with white patients, minority patients with ICH were significantly younger; were less likely to have a history of atrial fibrillation, coronary artery disease/previous myocardial infarction, carotid stenosis, peripheral vascular disease, and dyslipidemia; but were more likely to have diabetes mellitus (all P values <0.001). Black patients with ICH were more likely smokers and had hypertension. Stroke severity, measured by NIHSS, was documented in 38.3% of patients (white 37.5%, black 38.1%, Hispanic 42.6%, and Asian 42.7%). Among patients with ICH and NIHSS recorded, all minority groups had more severe strokes when compared with white patients (NIHSS median, 9, 10, 10, and 11 for white, black, Hispanic, and Asian, respectively; P<0.001). Patients with NIHSS documented were similar to NIHSS missing patients in terms of demographics and comorbidities (Table I in the online-only Data Supplement). There were significant variations across the 4 racial/ethnic groups in terms of hospital characteristics (Table 1 ). In general, black patients were more likely to be treated at large, academic hospitals with high volume. White patients were less likely to be treated at academic hospitals but more likely to be treated at primary stroke centers.
Performance Measures
Individual performance measures in ICH varied by race and ethnicity (Table 2 ). DVT prophylaxis, rehabilitation assessment, dysphagia screening, and stroke education rates were generally higher in minority ICH population. After adjustment for both patient and hospital-level characteristics, black patients were more likely to receive DVT prophylaxis (adjusted odds ratio [ 
Outcome Measures
The overall in-hospital mortality rate was 26.2%. Black (23.0%), Hispanic (22.8%), and Asian patients (25.3%) were less likely than white patients (27.6%) to die in hospital (Table 4) . After adjustment for patient and hospital characteristics, all minority groups had significantly lower odds of dying in hospital (black: OR, 0.91; 95% CI, 0.87-0.95; Hispanic: OR, 0.85; 95% CI, 0.80-0.91; Asian: OR, 0.87; 95% CI, 0.81-0.93; all P<0.001; Table 5 ) when compared with whites. These mortality differences remained after further adjustment for stroke severity in patients with NIHSS recorded (n=47 408). Stratified analyses by age found a similar 
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pattern of lower odds of death for minorities in each age stratum although the survival advantage was more prominent in older age groups (Figure) . Black, Hispanic, and Asian patients were less likely to be discharged to a hospice or treated with comfort measures when compared with whites ( (Table 5 ). In contrast, black (mean 10.8 days), Hispanic (9.6 days), and Asian (9.6 days) patients had significantly longer hospital stay than whites (8.7 days) and higher odds of exceeding the median length of day of 5 days. The length of hospital stays were also longer in minorities among both stroke survivors and patients who died in hospital (Table 4 ). In contrast, there were no clear racial/ethnic patterns in discharge destination or in ambulatory status at discharge, except that Hispanics had higher odds of being discharge home and blacks had lower odds of being discharged to an inpatient rehabilitation facility.
Discussion
In this large cohort of hospitalized patients with ICH in the United States, we examined racial/ethnic differences in ICH care processes and clinical outcomes. Although performance measures were similar in many respects, there was higher level of conformity with DVT prophylaxis (black and Asian), rehabilitation assessment (black), dysphagia screening (black, Hispanic, and Asian), and stroke education (black) in minority patients with ICH. Importantly, we found a consistent pattern of lower in-hospital mortality, longer length of stay, and reduced odds of receiving hospice care or treated with comfort measure in minority patients. These findings were robust across several subgroup analyses and stratified analyses.
In contrast to concerns that minority patients may receive less evidence-based care than white patients, we found evidence that minority patients had higher odds of receiving certain performance measures relative to whites. Although it is possible that these observed differences could simply reflect differences in access to care rather than racial/ethnic based disparity, for example, hospitals that admitted a greater proportion of black patients with ICH were larger, academic hospitals with higher ICH volume, these differences persisted after controlling for both patient and hospital characteristics. Our findings of lower conformity with smoking cessation measure and delay in brain imaging require targeted attention. Cigarette smoking is one of the most important modifiable risk factors for ischemic stroke and coronary artery disease, for which ICH survivors are at substantial risk. 17, 18 Failure in smoking cessation could lead to increased risk of recurrent stroke and other health conditions in minority smokers. This is especially important in blacks where we found smoking rates to be almost double that of the other racial groups. Rapid neuroimaging with CT or MRI is one of the few American Heart Association/American Stroke Association class I recommendations for ICH. 19 A previous study investigating the quality 20 Our study corroborates this finding in ICH, with a longer delay in brain imaging in blacks. Importantly, door to CT ≤25 minutes only achieved in less than one third of all patients with ICH. Because it is almost impossible to know symptoms are because of ischemia or hemorrhage without CT or MRI scan, improvements are clearly needed to reduce in-hospital evaluation delays in all patients with stroke regardless of race/ethnicity and stroke type.
Our research represents the largest study to examine racial/ ethnic differences in ICH outcomes. In contrast to the prevailing views of greater mortality rates in blacks for every stroke subtype, 21 we found lower in-hospital all-cause mortality rates for black, Hispanic, and Asian patients with ICH. These data highlight the difference between mortality and case-fatality. The excess mortality in minorities is likely because of higher incidence. Once they had a stroke attack, however, minority patients with ICH might have better short-term survival than white patients. The explanation for this gap is complex because differences in outcomes can be attributable to variation in patient case-mix, quality of care delivered by the hospital, or preferences for particular treatments. 22 Although it is possible that observed mortality differences could simply reflect differences in patient characteristics, the racial/ethnic differences persist after controlling for observed patient characteristics, including stroke severity in NIHSS complete records. Although age might also play an important role in ICH mortality, we observed a consistent pattern of lower risk of death in each age stratum. Nonetheless, it is possible that our findings are the result of other important unmeasured clinical characteristics, such as the location of ICH, hematoma volume, the presence and amount of intraventricular hemorrhage, blood pressure control, surgical intervention, and other severity measure including the Glasgow Coma Scale. [23] [24] [25] [26] The mortality differences are unlikely to because of adherence to performance measures. Smoking cessation, rehabilitation assessment, and stroke education are discharge performance conditional on survival. Therefore, they cannot be a cause of observed mortality difference. Although there is evidence of higher level conformity with DVT prophylaxis and dysphagia screening in minority patients, these differences are unlikely large enough to have a measurable effect on in-hospital outcomes because of pulmonary embolism or aspiration pneumonia. 27 Despite lack of treatment of proven benefit during the acute phase, it is generally agreed that the overall aggressiveness of ICH care might be critically important in determining patient outcomes. 19 Previous studies found withdrawal of support or early care limitations are independent predicators of shortterm or long-term mortality after ICH. [28] [29] [30] [31] [32] [33] In a chart review of 1421 patients with ICH in a single academic center, withholding or withdraw of life-sustaining intervention was the most common immediate cause of death (68%), followed by brain death (28%). 31 This study found compared with white LOS indicates length of stay. *Exclude death, discharge to hospice, or discharge information missing (home, skilled nursing facility, and inpatient rehabilitation) or exclude death and discharge information missing (hospice).
†Nov 2009 and later.
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patients, other race/ethnic groups were less likely to have care withdrawn or limited early and more likely to progress to brain death. In another evaluation of 8233 patients with ICH from 234 hospitals, in-hospital mortality is significantly influenced by the hospital overall aggressiveness of care. 34 Therefore, inhospital mortality after ICH may be more reflective of patient/ family preferences toward end-of-life care rather than the provision of evidence-based care. Similar to a Veterans Affairs evaluation of do-not-resuscitate in patients with stroke, 33 we found consistent patterns of longer length of stay, lower in-hospital mortality, and fewer discharge to hospice and comfort care in black, Hispanic, and Asian patients even after accounting for observed patient case-mix and hospital characteristics. These data suggested that care provided to patients with ICH may vary by race and some of the differences in outcomes may be mediated by the overall aggressiveness of care. It remains unclear however, whether the higher mortality rate and more frequent use of comfort measure in whites are reflective of patient/family preferences, treatment futility, or failure to provide appropriate care to patients who still have the possibility of favorable outcomes. 35 Therefore, if mortality is to be one of the metrics to quantify ICH care quality, great caution should be undertaken in interpreting these results.
Our study has limitations. First, the performance and inhospital outcome measures are based on the accuracy of data abstraction. Although not every data field in the current study were independently audited by external chart review, we previously demonstrated high fidelity for key variables in the GWTG-Stroke registry. 13 A related issue is the race/ethnicity status, which may have been self-designated by patients or assigned by hospital personnel and optional reporting of hemorrhagic stroke patients in the registry. The degree to which race/ethnicity misclassification or case selection Figure. Racial/ethnic differences in mortality: age-stratified analysis compared with white patients. actually occurred remains unknown. Second, our study is observational. Any causal relationship cannot be concluded. In particular, the GWTG-Stroke did not have information on causes of death and the exact clinical circumstance of treatment decision, so that deaths related to comfort measure and other end-of-care could not be evaluated completely. Third, we included a comprehensive list of prognostic factors for risk adjustment; residual measured or unmeasured variables may not be balanced between the racial/ethnic groups and may also account for some of these findings. In particular, NIHSS was only documented in <40% of the patients with ICH. However, it assures that NIHSS-documented patients seem comparable with non-NIHSS-documented patients. And more importantly, the findings of lower in-hospital mortality rates in black, Hispanic, and Asian patients with ICH were consistent among the overall study population and patients with complete NIHSS, when stroke severity by NIHSS was included in the models as a covariate. Fourth, our mortality estimates were based on the registry data. We cannot exclude the possibility of a larger proportion of out-of-hospital death in minorities, such that the sickest minority patients never even make it into the registry. 21 Fifth, except for in-hospital mortality, we were unable to assess other outcomes measures, such as long-term mortality, quality of life, and functional status because these measures were not collected in the GWTG-Stroke registry. In addition, in-hospital mortality might be confounded by length of stay and hospital discharge practices. However, it could be argued that confounding in length of stay is more likely to be against minority patients because they may end up dying in hospital because of relatively longer hospital stay, whereas white patients with ICH may die after discharge that would not be captured in the registry. Finally, the GWTG-Stroke Registry is a voluntary program. Hospitals participate based on their level of interest in quality improvement in stroke care and their capacity to fulfil the requirement. Therefore, the generalizability of our findings to non-GWTG-Stroke hospitals remains to be established. However, the GWTG-Stroke Registry is the largest stroke registry in the United States, covering 71.7% of US population as of 2013. In addition, ICH tends to be concentrated at large teaching hospitals. Given the higher representation of high-volume and academic centers in the GWTG-Stroke registry, our study population may be representative of patients with ICH in the United States. Nevertheless, these findings in terms of quality of care and outcomes may not apply to hospitals not participating in GWTG-Stroke or similar quality improvement initiatives.
In conclusion, in this large national sample of patients with ICH, we found higher level of conformity with certain ICH care processes and lower risk-adjusted mortality in black, Hispanic, and Asian patients with ICH when compared with their white counterparts. Additional research is warranted to understand what drives the racial/ethnic variations in adherence to evidence-based care and mortality and to develop the most appropriate metrics to measure ICH care quality and outcomes.
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